
Galecto GLTO
Galecto Kurzfristige Verbindlichkeiten | GLTO
Kurzfristige Verbindlichkeiten Jährlich Galecto
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.1 M | 1.2 M | 5.83 M | 11.1 M | 4.54 M | 5.57 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 20.1 M | 1.2 M | 8.05 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Celsion Corporation
CLSN
|
4.62 M | - | -6.63 % | $ 13.9 M | ||
|
Qilian International Holding Group Limited
QLI
|
41.6 M | - | -6.08 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
6.4 M | - | 1.35 % | $ 17.8 M | ||
|
Synthetic Biologics
SYN
|
10 M | - | 1.32 % | $ 16.2 M | ||
|
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B | ||
|
BioXcel Therapeutics
BTAI
|
53.9 M | $ 1.19 | 5.31 % | $ 14.5 M | ||
|
I-Mab
IMAB
|
412 M | - | - | $ 866 M | ||
|
BeyondSpring
BYSI
|
13.6 M | $ 0.84 | 34.27 % | $ 34.5 M | ||
|
Corner Growth Acquisition Corp.
COOL
|
30.2 K | - | -0.89 % | $ 114 M | ||
|
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
Cerus Corporation
CERS
|
101 M | $ 2.98 | 4.93 % | $ 568 M | ||
|
Compugen Ltd.
CGEN
|
22.6 M | $ 2.41 | 4.17 % | $ 225 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
47.5 M | - | - | $ 269 M | ||
|
Завод ДИОД
DIOD
|
105 M | - | - | - | ||
|
Galera Therapeutics
GRTX
|
645 K | - | -32.59 % | $ 7.61 M | ||
|
Hepion Pharmaceuticals
HEPA
|
299 K | - | -18.79 % | $ 39.3 K | ||
|
ARCA biopharma
ABIO
|
15.4 M | - | 1052.0 % | $ 415 M | ||
|
Champions Oncology
CSBR
|
19.9 M | $ 5.1 | 2.63 % | $ 70.5 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
42.3 M | - | -1.58 % | $ 28.1 M | ||
|
Adial Pharmaceuticals
ADIL
|
1.4 M | $ 3.98 | 1.86 % | $ 2.66 M | ||
|
Generation Bio Co.
GBIO
|
35.1 M | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
AnaptysBio
ANAB
|
38.6 M | $ 58.47 | 4.37 % | $ 1.68 B | ||
|
Anika Therapeutics
ANIK
|
21.9 M | $ 21.5 | 1.56 % | $ 308 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M | - | -4.36 % | $ 27 M | ||
|
Gracell Biotechnologies
GRCL
|
221 M | - | - | $ 3.37 B | ||
|
Aurinia Pharmaceuticals
AUPH
|
93.7 M | $ 15.47 | 1.91 % | $ 2.08 B | ||
|
GlycoMimetics
GLYC
|
36.1 M | - | 9357.83 % | $ 1.01 B | ||
|
AVROBIO
AVRO
|
9.67 M | - | 1083.1 % | $ 745 M | ||
|
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B | ||
|
Bicycle Therapeutics plc
BCYC
|
57 M | $ 3.9 | 0.24 % | $ 270 M | ||
|
Beam Therapeutics
BEAM
|
96.9 M | $ 26.75 | 0.91 % | $ 2.65 B | ||
|
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | ||
|
BioMarin Pharmaceutical
BMRN
|
759 M | $ 67.36 | 0.99 % | $ 12.9 B | ||
|
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M |